Tiziana Life Sciences Ltd SEC filings TLSA
Tiziana Life Sciences Ltd has 492 filings in SEC EDGAR's recent list, going back to Nov 30, 2017. Its latest annual report, Form 20-F, was filed on May 1, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Sep 29, 2026 | Aug 15, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jul 21, 2026 |
| 4/A | Filing | Aug 7, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Aug 6, 2026 | Aug 4, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 3, 2026 |
| 3 | Initial insider ownership | Jul 23, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jun 21, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 12, 2026 |
| 3 | Initial insider ownership | May 22, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 28, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 12, 2025 | — |
| SC 13G | Ownership over 5% (passive) | May 4, 2022 | — |
| SC 13D | Ownership over 5% (active) | Jan 4, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 26, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Aug 12, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Mar 17, 2020 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Bermuda
- Headquarters
- London, England, United Kingdom
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1723069
- Former names
- Tiziana Life Sciences plc (until Oct 21, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.